BD4992541
Manganese(II)bis(acetylacetonate) , 98% , 14024-58-9
Synonym(s):
2,4-Pentanedione manganese(II) derivative;Bis(acetylacetonato)manganese(II), Bis(2,4-pentanedionato)manganese(II);Manganese(II) acetylacetonate;Manganous acetylacetonate;Mn(acac)2
CAS NO.:14024-58-9
Empirical Formula: C10H14MnO4
Molecular Weight: 253.15
MDL number: MFCD00000022
EINECS: 237-858-2
| Pack Size | Price | Stock | Quantity |
| 5g | RMB24.00 | In Stock |
|
| 25g | RMB79.20 | In Stock |
|
| 100g | RMB271.20 | In Stock |
|
| 500g | RMB955.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 248-250 °C (dec.)(lit.) |
| Boiling point: | 130.3°C |
| Density | 1,6 g/cm3 |
| bulk density | 550kg/m3 |
| storage temp. | Store below +30°C. |
| solubility | 11.5g/l |
| form | Powder |
| color | tan |
| Specific Gravity | 1.60 |
| Water Solubility | Soluble in water |
| Hydrolytic Sensitivity | 7: reacts slowly with moisture/water |
| Sensitive | Hygroscopic |
| BRN | 4157965 |
| Exposure limits | OSHA: Ceiling 5 mg/m3 NIOSH: IDLH 500 mg/m3; TWA 1 mg/m3; STEL 3 mg/m3 |
| Stability: | hygroscopic |
| InChI | 1S/2C5H8O2.Mn/c2*1-4(6)3-5(2)7;/h2*3,6H,1-2H3;/q;;+2/p-2/b2*4-3-; |
| InChIKey | ZQZQURFYFJBOCE-FDGPNNRMSA-L |
| SMILES | CC(=O)\C=C(\C)O[Mn]O\C(C)=C/C(C)=O |
| EPA Substance Registry System | Manganese, bis(2,4-pentanedionato-.kappa.O,.kappa.O')- (14024-58-9) |
Description and Uses
- Effect of Precursors on the Electrochemical Properties of Mixed RuOx/MnOx Electrodes Prepared by Thermal Decomposition.: This study investigates the impact of different precursors, including manganese(II) acetylacetonate, on the electrochemical properties of mixed RuOx/MnOx electrodes. The findings highlight the importance of precursor selection in optimizing electrode performance for energy storage applications (Petrucci et al., 2022).
- Trinuclear coordination assemblies of low-spin dicyano manganese(II) (S = 1/2) and iron(II) (S = 0) phthalocyanines with manganese(II) acetylacetonate, tris(cyclopentadienyl)gadolinium(III) and neodymium(III).: This research explores the formation and properties of trinuclear coordination complexes involving manganese(II) acetylacetonate. These complexes exhibit unique magnetic properties that have potential applications in molecular magnetism and materials science (Romanenko et al., 2022).
- ZIF-8 Membrane Permselectivity Modification by Manganese(II) Acetylacetonate Vapor Treatment.: This paper demonstrates how manganese(II) acetylacetonate vapor treatment can enhance the permselectivity of ZIF-8 membranes. Such modifications improve membrane performance in gas separation processes, offering advancements in industrial applications (Hayashi et al., 2021).
- Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.: The study focuses on the synthesis of manganese oxide nanoparticles using manganese(II) acetylacetonate as a precursor. It outlines methods to control nanoparticle size and composition, which are critical for applications in catalysis and biomedicine (Martinez de la Torre et al., 2020).
- Manganese Oxide Nanoparticle Synthesis by Thermal Decomposition of Manganese(II) Acetylacetonate.: This research details the synthesis of manganese oxide nanoparticles via the thermal decomposition of manganese(II) acetylacetonate. The resulting nanoparticles show promise for use in various catalytic and biomedical applications (Martinez de la Torre and Bennewitz, 2020).
Safety
| Symbol(GHS) | ![]() ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302+H312+H332-H315-H319-H335-H351 |
| Precautionary statements | P280-P301+P312-P302+P352+P312-P304+P340+P312-P305+P351+P338-P308+P313 |
| target organs | Respiratory system |
| PPE | dust mask type N95 (US), Eyeshields, Gloves |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22-36/37/38-40 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| RTECS | OO9350000 |
| TSCA | TSCA listed |
| HS Code | 2914 19 90 |
| Storage Class | 13 - Non Combustible Solids |
| Hazard Classifications | Acute Tox. 4 Dermal Acute Tox. 4 Inhalation Acute Tox. 4 Oral Carc. 2 Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |








